U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Postmarket Drug Safety Information for Patients and Providers
  5. Mirtazapine (marketed as Remeron) Information
  1. Postmarket Drug Safety Information for Patients and Providers

Mirtazapine (marketed as Remeron) Information

Mirtazapine is a prescription medicine used to treat depression. It is marketed as mirtazapine, Remeron, and Remeron Soltab.

 
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program using the contact information at the bottom of this page.

Related Information

Regulatory History and Labeling from Drugs@FDA

Back to Top